Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership with eXmoor pharma
September 24, 2024 05:30 ET
|
Quell TX
Multi-year agreement focuses on the manufacture of multiple CAR-Treg product candidates for Phase 1/2 clinical studies Partnership builds on long-term relationship to provide Quell with additional...
3D Motion Capture System Market to Reach USD 726.08 Million by 2032, Driven by Rising Need for High-Precision Motion Data and the Increasing Adoption in Professional Sectors | by SNS Insider
September 17, 2024 06:49 ET
|
SNS Insider pvt ltd
Austin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Market Overview: The 3D Motion Capture System Market Share was valued at USD 222.65 Million in 2023 and is expected to reach USD 726.08 Million by 2032,...
Leg Shortening Surgery at Limbplastx Institute: Pioneering Excellence in Limb Lengthening, Reconstruction, and Transgender Care
September 10, 2024 13:00 ET
|
Limbplastx Institute
Henderson, Nevada, Sept. 10, 2024 (GLOBE NEWSWIRE) -- LimbplastX is widely recognized for its innovative and advanced techniques for cosmetic limb-lengthening, catering to patients from around the...
Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH
September 09, 2024 07:00 ET
|
Akero Therapeutics Inc.
Outcomes is the third study in the Phase 3 SYNCHRONY clinical trial program SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a...
Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024 16:05 ET
|
Akero Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious...
Energy-based Aesthetic Devices Focused Insights 2024-2029: Vendors Focus on Extensive R&D, Marketing, and Expanding Product Portfolios to Gain Competitive Advantages
August 21, 2024 06:25 ET
|
Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Energy-based Aesthetic Devices Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Energy-based...
[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 13, 2024 00:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Aesthetics Injectables Market Size, Trends and Insights By Product Type...
Akero Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 09, 2024 07:00 ET
|
Akero Therapeutics Inc.
-- Initiated Phase 3 SYNCHRONY Outcomes Trial of Lead Candidate Efruxifermin (EFX) in Patients with Compensated Cirrhosis (F4) Due to MASH -- Presented Poster and Late-breaking Oral Presentation on...
The Niche Research Report: Unleashing Potential with Breakthrough Innovations in Facial Injectables Market
August 05, 2024 09:00 ET
|
The Niche Research
Wilmington, Delaware, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The facial injectables market is witnessing robust growth, driven by the rising demand for non-invasive aesthetic treatments. Trends indicate...
Vagus Nerve Stimulation Market Set to Surge to USD 1074.62 Million By 2032 | Increasing Incidences of Neurological Diseases Such as Migraine and Epilepsy Boost Market Growth
July 26, 2024 10:35 ET
|
SNS Insider pvt ltd
Austin, July 26, 2024 (GLOBE NEWSWIRE) -- The Vagus Nerve Stimulation Market Size was valued at USD 456.88 million in 2023 and is expected to reach USD 1074.62 million by 2032 and grow at a CAGR of...